Aviado · Research
Longevity Daily
Thursday, May 21, 2026
Listen
Today's Brief
Today's issue opens with an uncomfortable finding for supplement-takers: a 7-year longitudinal study tied calcium supplementation to a threefold increase in cognitive decline risk in older women. Alongside it, scientists have rewritten metformin's mechanism of action, and a new PNAS paper decodes longevity secrets from the world's oldest-living vertebrate. A Guardian-covered Oxford analysis meanwhile puts at least 80% of aging-related disease squarely in your hands. And for context, Science News covers a new book asking whether much of the anti-aging industry is built on wishful thinking dressed up as data.
10 stories4 peer-reviewed
Cognitive Health & Neuroprotection
Calcium Supplements Linked to a Threefold Cognitive Decline Risk in 7-Year Study
A prospective cohort study following 227 older women (mean age 79.9) over seven years found that calcium supplement use was independently associated with a 3.64-fold increased risk of cognitive decline — even after adjusting for age, obesity, physical activity, diet, vitamin D intake, and comorbidities. Cognitive decline occurred in 26% of all participants, but supplementers faced dramatically elevated odds. This is an observational study with a relatively small sample, so it does not prove causation — but the signal is striking enough to warrant a conversation with your doctor before continuing or starting calcium pills. The authors explicitly call for more research into the neurological safety of calcium supplementation in aging populations.
Read more →'Longevity Gene' May Shield the Aging Brain from Dementia, Aging Cell Study Finds
Research published in Aging Cell — funded by the National Institute on Aging, the Hevolution Foundation, and the Glenn Foundation for Medical Research — identifies a specific gene that may protect the brain from age-related decline and dementia. The discovery adds to growing evidence that variation in longevity-linked genetic pathways can meaningfully reduce neurodegeneration risk and narrows the target list for future prevention strategies. This is early-stage research without immediate clinical application, but the funding pedigree and journal suggest it will be closely followed.
Read more →Supplements & Compounds
Metformin Doesn't Work the Way We Thought — New Research Rewrites the Mechanism
Metformin has been a longevity community staple for decades, but researchers now believe its primary glucose-lowering effect operates in intestinal cells — not the liver, as long assumed. The study shows metformin suppresses mitochondrial energy production in gut cells, forcing them to absorb more circulating blood glucose as compensation. This doesn't change the drug's real-world performance, but identifying the correct mechanism could accelerate development of better-targeted metabolic and longevity drugs.
Read more →Popular Workout Supplement May Blunt the Heart's Beneficial Adaptations to Exercise — in Women
A Dalhousie University study found that a widely used athletic performance supplement may interfere with cardiac adaptations to exercise, with the effect concentrated in female participants. The finding adds to a growing body of evidence that some commonly taken supplements have sex-specific effects that most research — historically conducted in male subjects — has missed entirely. The specific supplement wasn't disclosed in early coverage; click through to see the full findings and whether your stack is implicated.
Read more →Research & Papers
Greenland Shark Genome Unlocks Genetic Secrets of Earth's Longest-Lived Vertebrate
Scientists have published a chromosome-level assembly of the Greenland shark genome in PNAS — the first genomic study of a species estimated to live 392 ± 120 years. Analysis revealed expanded gene families linked to enhanced DNA repair, cancer resistance, and unique chromatin-stabilizing mutations in histone H1.0, plus a potential link between ferroptosis suppression and extreme longevity. These are several steps removed from human application, but this is basic science at the highest level — a concrete molecular blueprint of what enables the longest vertebrate lifespan on Earth.
Read more →HIV Treatment Reverses 3.7 Years of Accelerated Biological Aging
People living with HIV experience significantly accelerated biological aging — but after roughly 18 months of antiretroviral therapy, participants showed a statistically significant 3.7-year reduction in biological age, with continued treatment driving further improvement. The finding is proof-of-concept that biological age, as measured by epigenetic clocks, is not fixed: addressing systemic inflammation and immune dysregulation can move the needle in the right direction. For the broader longevity field, it's one of the clearest human demonstrations yet that biological aging is at least partially reversible.
Read more →'Morbid': The Book That Wants You to Stop Falling for Anti-Aging Hype
Scientist Saul Justin Newman — known for exposing methodological flaws in supercentenarian data — has written a book systematically challenging popular longevity research and anti-aging medicine. Newman argues that much of the evidence driving the longevity industry rests on bad data, confounded studies, and findings that don't replicate when scrutinized. For anyone investing time, money, or health decisions in this space, it's a valuable corrective — the best longevity strategies are those that survive the hardest questions.
Read more →Lifestyle & Nutrition
Your Daily Circadian Rhythms May Be Slowing — or Accelerating — Your Biological Age
New research covered by ScienceAlert finds that the consistency and regularity of daily biological rhythms — sleep-wake cycles, meal timing, activity patterns — correlates with biological age as measured by epigenetic clocks. People with more disrupted or irregular rhythms showed higher biological ages relative to their chronological age. The practical implication is simple: consistency of timing matters for aging, not just what you do but when — and at what regularity — you do it.
Read more →Oxford Analysis: At Least 80% of Age-Related Ill Health Is Within Your Control
A report from the Oxford Longevity Project, launched at the Smart Ageing Summit, argues that individuals have far greater control over their health trajectory in old age than commonly understood — with at least 80% of age-related ill health attributable to modifiable lifestyle and behavioral factors. This is a more forceful claim than the familiar "genetics accounts for ~25% of longevity" framing, and it reframes aging not as something that happens to you, but as something you largely author. The report's full methodology isn't available in current coverage, but the argument aligns with a growing body of work in epigenetics and lifestyle medicine.
Read more →Industry & Policy
China Launches Its First National Longevity Medicine Physician Training Program
China has unveiled the world's first nationally standardized, competency-based physician education program in longevity medicine — a signal that the world's most populous aging society is beginning to formalize this emerging specialty at a systemic level. The initiative reflects mounting healthcare pressure from China's rapidly aging population and mirrors similar pushes toward longevity-informed clinical training emerging in the U.S. and Europe. When longevity medicine becomes a taught medical specialty with national standards, it accelerates funding, credentialing, and ultimately clinical adoption of the field's best-validated interventions.
Read more →